Process Development of Amlodipine and Olmesartan Medoxomil Tablets: Process Development of Amlodipine and Olmesartan Medoxomil Tablets 10/40 Mg. Este artículo no está disponible.
Idioma: inglés
Editorial: LAP LAMBERT Academic Publishing, 2021
- Tapa blanda
- Nuevo
Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Vendedor de 5 estrellas
Vendedor de IberLibro desde 25 de marzo de 2015
No disponible
Tapa blanda
Condición: Nuevo
EUR 45,41
Descripción del artículo del vendedor
In English.
N° de ref. del artículo ria9786203409338_new
- Título
- Process Development of Amlodipine and Olmesartan Medoxomil Tablets: Process Development of Amlodipine and Olmesartan Medoxomil Tablets 10/40 Mg
- Autor
- Behera, Gayatri; Behera, Jayashree; Barik, Binapani
- Editorial
- LAP LAMBERT Academic Publishing
- Año de publicación
- 2021
- Estado
- New
- Encuadernación
- Encuadernación de tapa blanda
- Idioma
- inglés
- ISBN 10
- 6203409332
- ISBN 13
- 9786203409338
- Peso del artículo
- 240 gramos
The present study was focused on process development of amlodipine and olmesartan medoxomil tablet 10/40mg. Amlodipine and Olmesartan medoxomil is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure . The Content uniformity was found of both the drugs were performed. Release study was conducted in pH 6.8 buffer media. Furthermore, dissolution profile comparison was carried out using similarity factor (f2) and the similarity factor of Amlodipine and Olmesartan Medoxomil found to be 73. Other studies Like DSC and FTIR studies reported compatibility of Amlodipine besylate with excipients like Cross Carmel lose sodium was performed shows no chemical interaction between drug and excipients. Dissolution profile of Test and Reference standard found to be similar, Similarity factor (f2) is 73.
“Sinopsis” puede pertenecer a otra edición de este título.